Panitumumab vs Bevacizumab Added to Standard First-line Chemotherapy and Overall Survival Among Patients With RAS Wild-type, Left-Sided Metastatic Colorectal Cancer: A Randomized Clinical Trial
Takeda
Jun Watanabe; Kei Muro; Kohei Shitara; Kentaro Yamazaki; Manabu Shiozawa; Hisatsugu Ohori; Atsuo Takashima; Mitsuru Yokota; Akitaka Makiyama; Naoya Akazawa; Hitoshi Ojima; Yasuhiro Yuasa; Keisuke Miwa; Hirofumi Yasui; Eiji Oki; Takeo Sato; Takeshi Naitoh; Yoshito Komatsu; Takeshi Kato; Masamitsu Hihara; Junpei Soeda; Toshihiro Misumi; Kouji Yamamoto; Kiwamu Akagi; Atsushi Ochiai; Hiroyuki Uetake; Katsuya Tsuchihara; Takayuki Yoshino
Department of Biostatistics, Yokohama City University School of Medicine, Yokohama, Japan. ; Department of Biostatistics, Yokohama City University School of Medicine, Yokohama, Japan.